Status:

UNKNOWN

Verapamil in Supraclavicular Brachial Plexus Block

Lead Sponsor:

Assiut University

Conditions:

Regional Anesthesia Morbidity

Eligibility:

All Genders

18-60 years

Phase:

NA

Brief Summary

Supraclavicular brachial plexus block (SCBPB) is the common approach to provide surgical anesthesia of upper limb. The effects of single-injection brachial plexus nerve blocks recede after several hou...

Detailed Description

Strategies to prolong brachial plexus nerve blocks analgesia beyond the pharmacological duration of the local anaesthetic used include placement of indwelling perineural catheters to allow prolonged i...

Eligibility Criteria

Inclusion

  • ASA I-II patients older than 18years and scheduled for forearm and hand surgeries like :
  • fracture radius and ulna.
  • cut wrists.

Exclusion

  • allergy to the study drugs,
  • skin infection at site of needle puncture,
  • significant organ dysfunction, coagulopathy, drug or alcohol abuse, epilepsy, and psychiatric illness that would interfere with perception and assessment of pain.

Key Trial Info

Start Date :

January 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 1 2023

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT05183997

Start Date

January 1 2022

End Date

February 1 2023

Last Update

January 11 2022

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Verapamil in Supraclavicular Brachial Plexus Block | DecenTrialz